These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6364947)

  • 1. [Redistribution of the coronary blood flow, functional improvement of the ischemic myocardium and reduction of the size of an experimental infarction by molsidomine].
    Berdeaux A; Giudicelli JF
    Ann Cardiol Angeiol (Paris); 1983 Dec; 32(8):511-5. PubMed ID: 6364947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of molsidomine and nitroglycerin on the regional blood flow in the normal and acutely ischemic myocardium (author's transl)].
    Scholtholt J; Fiedler VB; Keil M
    Arzneimittelforschung; 1978; 28(9):1619-24. PubMed ID: 113017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacological basis of therapy with molsidomine].
    Bassenge E
    Herz; 1982 Oct; 7(5):296-306. PubMed ID: 6897544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cellular mechanism of action of molsidomine. Bioinduction of prostacyclin].
    Poincelot B; Russo-Marie F
    Ann Cardiol Angeiol (Paris); 1983 Dec; 32(8):535-7. PubMed ID: 6421223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of molsidomine on coronary collateral blood flow in acute myocardial ischemia.
    Gross GJ; Gharaibeh M
    Eur J Pharmacol; 1980 Oct; 67(1):111-4. PubMed ID: 6893436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of molsidomine during the cold test in stable coronary insufficiency under beta-blocker treatment].
    Zygelman M; Neukirch F; Mérillon JP; Dahan M; Trouillet JL; Juliard JM; Pansard Y; Gourgon R
    Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1383-9. PubMed ID: 6150693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of molsidomine on the coronary circulation in anesthetized dogs.
    Fiedler VB; Nitz RE
    Basic Res Cardiol; 1982; 77(3):270-7. PubMed ID: 6896818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The activity of molsidomine in experimental models of ischemic cardiac disease.
    Nitz RE; Martorana PA
    Am Heart J; 1985 Mar; 109(3 Pt 2):631-6. PubMed ID: 3919549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of molsidomine on intramyocardial pressure and regional myocardial blood flow in the canine ischemic myocardium.
    Kinoshita M; Mashiro I; Mitsunami K; Fukuhara T; Motomura M; Bito K; Kawakita S
    Jpn Circ J; 1985 May; 49(5):507-15. PubMed ID: 3839541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SIN-1, the main metabolite of molsidomine, inhibits prostaglandin endoperoxide analogue- and arachidonic acid-induced platelet aggregation as well as platelet thromboxane A2 formation.
    Block HU; Förster W; Heinroth I
    Arzneimittelforschung; 1982; 32(3):189-94. PubMed ID: 6896278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molsidomine, a coronary drug with platelet-aggregating inhibitory activity].
    Silberbauer K; Slany J; Sinzinger H; Punzengruber C
    Z Kardiol; 1982 Aug; 71(8):539-43. PubMed ID: 6753382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of molsidomine on left ventricular function in coronary heart disease (author's transl)].
    Meyer J; Sprauer R; Krebs W; Erbel R; Schweizer P; Effert S
    Dtsch Med Wochenschr; 1980 Aug; 105(35):1210-6. PubMed ID: 6893579
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hemodynamic and coronary effects of molsidomine in patients with stable coronary insufficiency in the basal state, during an atrial stimulation test and a cold test].
    Gourgon R; Neukirch F; Zygelman M; Michel PL; Mérillon JP; Pansard Y; Squara P; Laurent S; Dahan M; Juliard JM
    Ann Cardiol Angeiol (Paris); 1983 Dec; 32(8):529-34. PubMed ID: 6689395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of molsidomine on the regional distribution of cardiac output in the anaesthetized dog (author's transl)].
    Scholtholt J; Fiedler VB; Keil M
    Arzneimittelforschung; 1978; 28(9):1612-9. PubMed ID: 582566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemodynamic effects of molsidomine in patients with severe chronic coronary disease.
    Crexells C; Lidón RM; Augé JM; Bosch X; Pina C; Garcia J; Oriol A
    Eur Heart J; 1985 Dec; 6(12):1032-9. PubMed ID: 3841658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of molsidomine, nitroglycerin, and isosorbide dinitrate on the coronary circulation, myocardial oxygen consumption, and haemodynamics in anaesthetized dogs.
    Fiedler VB; Nitz RE
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Aug; 317(1):71-7. PubMed ID: 6792547
    [No Abstract]   [Full Text] [Related]  

  • 17. [Acute hemodynamic effects of molsidomine in man].
    Tartulier M; Ferrini M; Boutarin J; Ritz B
    Ann Cardiol Angeiol (Paris); 1983 Dec; 32(8):517-21. PubMed ID: 6689394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newer concepts in the pathophysiology of ischemic heart disease.
    Kirk ES; Factor S; Sonnenblick EH
    G Ital Cardiol; 1984 Nov; 14(11):881-91. PubMed ID: 6526205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial cellular alterations during myocardial ischemia and evolving infarction.
    Willerson JT; Buja LM
    Postgrad Med; 1988 Feb; Spec No():69-75. PubMed ID: 2894662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic effects of molsidomine on weight sustaining isometric exercise in patients with ischemic heart disease.
    Tsujibayashi T; Niwa A; Taniguchi K; Takeuchi J
    Bull Tokyo Med Dent Univ; 1985 Dec; 32(4):163-7. PubMed ID: 3865742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.